Delivery Order SPE2DB20D3101-SPE2DB24FQTN2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,085.03 for the pharmaceutical product Ciproflox-Dexameth Otic Suspension (7.5 ml). The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $6,265.44, is for the delivery of Ciproflox-Dexameth Otic Suspension (7.5 ml) to support military healthcare programs. The award, which has a completion date of April 12, 2022, is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award is for medical supplies and pharmaceutical products provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to the Defense Logistics Agency (DLA). The $2,145.60 delivery order (SPE2DB20D3101|SPE2DB24FRAJ8) is for Ciproflox-Dexameth Otic Suspension 7.5mL, with a completion date of February 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a separate $750,000...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including the medication Ciproflox-Dexameth Otic Suspension. The contract has a ceiling value of $1,536.62 and an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $1,227.69 for the supply of Ciproflox-Dexameth Otic Suspension 7.5ML, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,535.14 firm fixed-price delivery order is for the supply of the medication Ciproflox-Dexameth Otic Suspension, with a period of performance through August 7, 2024. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,588.37 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Ciproflox-Dexameth Otic Suspension 7.5ML. This is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,027.89 for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,320.95 fixed-price delivery order is for the pharmaceutical product Ciproflox-Dexameth Otic Suspension 7.5 mL and has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,005.20 firm fixed-price delivery order is for the medical product "CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML" and has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQTN2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,266.86 firm fixed-price delivery order is for Ciproflox-Dexameth Otic Suspension, a pharmaceutical product. The award is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracts demonstrate Amerisourcebergen's role as a critical supplier of essential medications, devices, and other medical items to various federal agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/25/23 |